Nov 01, 2021 / 07:00AM GMT
Unidentified Company Representative -
[Interpreted] It is now time. We would like to begin financial results presentation session of Eisai Co., Ltd. for the second quarter fiscal 2021. This session is live streamed and distributed to those who are participating from telephone line. Those of you who are participating through the teleconference, please download the slides from our website and please click forward. Those of you who are watching live stream, please continue to watch the screen.
Now let me introduce the presenter today, Mr. Haruo Naito, Representative Corporate Officer and CEO. Now over to you, Mr. Naito, please.
Haruo Naito - Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director
[Interpreted] Thank you. This is Naito speaking. Now I would like to report to you the results recorded up until the end of the second quarter this fiscal year.
Now here, our overall P&L. As you see in the headline, Lenvima and other global brands, 4 in total, have steadily grown, and MORAb-202 and other strategic options have been made in
Q2 2022 Eisai Co Ltd Earnings Call Transcript
Nov 01, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers